Recombinant Human CD55/DAF Protein

Carrier Free

Catalog # Availability Size / Price Qty
2009-CD-050/CF

With Carrier

Catalog # Availability Size / Price Qty
2009-CD-050
R&D Systems Recombinant Proteins and Enzymes
1 Image
Product Details
Citations (6)
FAQs
Reviews

Recombinant Human CD55/DAF Protein Summary

Product Specifications

Endotoxin Level
<1.0 EU per 1 μg of the protein by the LAL method.
Activity
Measured by its binding ability in a functional ELISA. Recombinant Human CD55/DAF (Catalog # 2009-CD) binds to Recombinant Human CD97 His-tag with an ED50 of 1.50-15.0 μg/mL.
Source
Mouse myeloma cell line, NS0-derived human CD55/DAF protein
Human CD55
(Asp35-Ser353)
Accession # P08174.4
DI 6-His tag
N-terminus C-terminus
Accession #
N-terminal Sequence
Analysis
Asp35
Predicted Molecular Mass
36.0 kDa
SDS-PAGE
61-75 kDa, reducing conditions

Product Datasheets

You must select a language.

x

2009-CD (with carrier)

You must select a language.

x

2009-CD/CF (carrier free)

Carrier Free

What does CF mean?

CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.

What formulation is right for me?

In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.

2009-CD

Formulation Lyophilized from a 0.2 μm filtered solution in PBS with BSA as a carrier protein.
Reconstitution Reconstitute at 200 μg/mL in sterile PBS containing at least 0.1% human or bovine serum albumin.
Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 3 months, -20 to -70 °C under sterile conditions after reconstitution.

2009-CD/CF

Formulation Lyophilized from a 0.2 μm filtered solution in PBS.
Reconstitution Reconstitute at 200 μg/mL in sterile PBS.
Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 3 months, -20 to -70 °C under sterile conditions after reconstitution.
Reconstitution Calculator

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Background: CD55/DAF

CD55, also known as DAF or decay-accelerating factor, is a 70-75 kDa member of the RCA family of proteins. Human RCA (regulators of complement/C’ activation) proteins are products of chromosome 1 genes that are ubiquitously expressed on cells exposed to plasma complement proteins (1-4). A hallmark of RCA proteins is the presence of four to 30 SCRs (short consensus repeats; also called CCPs for C’ control protein modules) in their plasma-exposed regions. SCRs are characterized by a 60-65 amino acid (aa) module that contains a highly conserved Trp residue and two internal disulfide bonds that create a beta -barrel structure (1). Human CD55 is synthesized as a 381 aa precursor that contains a 34 aa signal sequence, a 319 aa mature region and a 28 aa C‑terminal prosegment (5, 6). The mature region contains four SCR modules and a C‑terminal O‑glycosylated extension (7). Following cleavage of the prosegment, a serine is exposed that serves as an anchor for a GPI-linkage (8). Multiple polymorphisms are found in the molecule. Alternate splicing also exists. One form that may not be translated shows an intron insertion in the prosegment, resulting in a 79 aa substitution for the standard C‑terminal 20 aas of the prosegment (6). Another form generates a truncated 199 aa precursor that cannot be membrane-bound and may not be secreted (9). Mature CD55 is 53% and 84% aa identical to mouse and monkey CD55, respectively. CD55 is known to bind CD97 via the first SCR (4). It also binds physiologically-generated C3 convertases with its second and third SCRs (7, 10). Binding results in an accelerated “decay”, or dissociation of active C3 convertases, thus blocking the development of C’ attack complexes on nonforeign cells (1, 2). Finally, viruses and bacteria are also known to utilize multiple SCR sites for infection (4).

References
  1. Herbert, A. et al. (2002) Biochem. Soc. Trans. 30:990. 
  2. Miwa, T. and W-C. Song (2001) Int. Immunopharmacol. 1:445. 
  3. Hourcade, D. et al. (2000) Immunopharmacology 49:103. 
  4. Lea, S. (2002) Biochem. Soc. Trans. 30:1014. 
  5. Medof, M.E. et al. (1987) Proc. Natl. Acad. Sci. USA 84:2007. 
  6. Caras, I.W. et al. (1987) Nature 325:545.
  7. Lukacik, P. et al. (2004) Proc. Natl. Acad. Sci. USA 101:1279.
  8. Moran, P. et al. (1991) J. Biol. Chem. 266:1250.
  9. Lublin, D.M. et al. (1994) Blood 84:1276.
  10. Williams, P. et al. (2003) J. Biol. Chem. 278:10691.
Entrez Gene IDs
1604 (Human); 13136 (Mouse)
Alternate Names
CD55 antigen; CD55 molecule, decay accelerating factor for complement (Cromer blood group); CD55; CR; CRdecay accelerating factor for complement (CD55, Cromer blood group system); CROMDAFcomplement decay-accelerating factor; DAF; decay accelerating factor for complement; TC

Citations for Recombinant Human CD55/DAF Protein

R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.

6 Citations: Showing 1 - 6
Filter your results:

Filter by:

  1. Decay-Accelerating Factor Creates an Organ-Protective Phenotype after Hemorrhage in Conscious Rats
    Authors: MO Simovic, MJ Falabella, TD Le, JJ DalleLucca, Y Li
    International Journal of Molecular Sciences, 2022-11-05;23(21):.
    Species: Rat
    Sample Types: In Vivo
    Applications: In Vivo
  2. MicroRNA-503-5p Inhibits the CD97-Mediated JAK2/STAT3 Pathway in Metastatic or Paclitaxel-Resistant Ovarian Cancer Cells
    Authors: GB Park, D Kim
    Neoplasia, 2019-01-09;21(2):206-215.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  3. Complement inhibition ameliorates blast-induced acute lung injury in rats: Potential role of complement in intracellular HMGB1-mediated inflammation
    Authors: Y Li, Z Yang, M Chavko, B Liu, OA Aderemi, MO Simovic, MA Dubick, LC Cancio
    PLoS ONE, 2018-08-22;13(8):e0202594.
    Species: Rat
    Sample Types: In Vivo
    Applications: In Vivo
  4. Overexpression of Human CD55 and CD59 or Treatment with Human CD55 Protects against Renal Ischemia-Reperfusion Injury in Mice
    Authors: AK Bongoni, B Lu, EJ Salvaris, V Roberts, D Fang, JL McRae, N Fisicaro, KM Dwyer, PJ Cowan
    J. Immunol., 2017-05-12;0(0):.
    Species: Mouse
    Sample Types: In Vivo
    Applications: In Vivo
  5. Broad spectrum activity of a lectin-like bacterial serine protease family on human leukocytes.
    Authors: Ayala-Lujan, Jorge Lu, Vijayakumar, Vidhya, Gong, Mei, Smith, Rachel, Santiago, Araceli, Ruiz-Perez, Fernando
    PLoS ONE, 2014-09-24;9(9):e107920.
    Species: Bacteria, Human
    Sample Types: Protein, Whole Cells
    Applications: Enzyme Assay, Enzyme Assay Substrate
  6. Decay-accelerating factor attenuates remote ischemia-reperfusion-initiated organ damage.
    Authors: Weeks C, Moratz C, Zacharia A, Stracener C, Egan R, Peckham R, Moore FD, Tsokos GC
    Clin. Immunol., 2007-07-12;124(3):311-27.
    Species: Mouse
    Sample Types: In Vivo
    Applications: In Vivo

FAQs

No product specific FAQs exist for this product, however you may

View all Proteins and Enzyme FAQs

Reviews for Recombinant Human CD55/DAF Protein

There are currently no reviews for this product. Be the first to review Recombinant Human CD55/DAF Protein and earn rewards!

Have you used Recombinant Human CD55/DAF Protein?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review